Viana VG, Viana EG, Leal VL, Andrade GC, Polate AT, Fuchs LC, et al. ORAL GLP-1 RECEPTOR AGONIST (ORFORGLIPRON) IN THE MANAGEMENT OF OBESITY AND TYPE 2 DIABETES. Editora [Internet]. 2026 Jan. 13 [cited 2026 Mar. 4];:43-55. Available from: https://sevenpubl.com.br/editora/article/view/8968